May 21, 2007 (Press Release) --
Zimulti scientific name is "rimonabant" so you may see it referred to by that name. A second name trademarked by Sanofi-Aventis, in addition to Zimulti, for rimonabant is Acomplia. You might see the drug referred to by either name; at this time it seems like Sanofi is likely to use the name Zimulti in America and Acomplia in Europe. As of June, 2006, when rimonbant was approved for sale in Europe, "Acommplia" was indeed the name chosen for European sale. For US sale, Sanofi could even pick a variant, such as "Accomplia," or an entirely different name. It is a new type of drug, that works with a new physical system discovered by scientists.
Put an end to obesity and buy Zimulti. Zimulti online is the intended name for Rimonabant for its launch in the US. It is basically an anti-obesity drug.
Zimulti can give respite to people those who have a BMI (Body Mass Index) greater than 30. BMI is a calculated value of your height in proportion to your weight. A high BMI level, increases your chances to be prone to health related issues like high blood pressure, type 2 diabetes, heart attack amongst others.
For more visit http://www.acomplia.ooblez.com/buy_zimulti.html
Put an end to obesity and buy Zimulti. Zimulti online is the intended name for Rimonabant for its launch in the US. It is basically an anti-obesity drug.
Zimulti can give respite to people those who have a BMI (Body Mass Index) greater than 30. BMI is a calculated value of your height in proportion to your weight. A high BMI level, increases your chances to be prone to health related issues like high blood pressure, type 2 diabetes, heart attack amongst others.
For more visit http://www.acomplia.ooblez.com/buy_zimulti.html

Zimulti can give respite to people those who have a BMI (Body Mass Index) greater than 30.
Email
Print
SPAM





